OTC and FDA Registration
Friday, September 27, 2019
FOSAPREPITANT (Fosaprepitant Dimeglumine) Injection, Powder, Lyophilized, For Solution [Baxter Healthcare Corporation]
Updated Date: Mon, 23 Sep 2019 00:00:00 EDT
from
https://fda.report/DailyMed/3ed3e0a9-a0a8-4555-9f73-2043e79e3398&version=2
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment